Excelsior Sciences
4 known investors
Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development. Its proprietary Blocc Chemistry platform uses AI-guided synthesis to accelerate drug discovery through machine-readable chemical building blocks and closed-loop learning.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
MB
Marty Burke
BG
Bartosz Grzybowski
MF
Michael FoleyCEO
JJ

Jana JensenCOO
Investors Β· 4
Frequently asked questions
- What does Excelsior Sciences do?
- Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development. Its proprietary Blocc Chemistry platform uses AI-guided synthesis to accelerate drug discovery through machine-readable chemical building blocks and closed-loop learning.
- Who founded Excelsior Sciences?
- Excelsior Sciences was founded by Marty Burke, Bartosz Grzybowski.
- Who are Excelsior Sciences's investors?
- Excelsior Sciences's investors include Khosla Ventures, Sofinnova Partners, Cornucopian Capital Management, Illinois Ventures.
